Australia markets closed

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.84+0.05 (+0.57%)
At close: 04:00PM EDT
8.88 +0.04 (+0.45%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
43,876
43,876
39,681
10,000
3,413
Cost of revenue
42,587
42,587
48,275
0
-
Gross profit
1,289
1,289
-8,594
10,000
-
Operating expenses
Research development
241,226
241,226
155,696
135,271
63,319
Selling general and administrative
110,822
110,822
81,599
57,682
25,258
Total operating expenses
351,349
351,349
237,133
192,775
88,028
Operating income or loss
-350,060
-350,060
-245,727
-182,775
-84,615
Interest expense
97
97
55
2,952
1,360
Total other income/expenses net
-1,087
-1,087
52
-825
-1,367
Income before tax
-332,128
-332,128
-239,476
-186,479
-87,006
Income tax expense
-4,062
-4,062
0
0
-
Income from continuing operations
-328,066
-328,066
-239,476
-186,479
-87,006
Net income
-328,066
-328,066
-239,476
-186,479
-87,006
Net income available to common shareholders
-328,066
-328,066
-239,476
-186,479
-87,006
Basic EPS
-1.46
-
-1.36
-1.49
-0.77
Diluted EPS
-1.46
-
-1.36
-1.49
-0.77
Basic average shares
198,763
-
175,537
125,348
112,466
Diluted average shares
198,763
-
175,537
125,348
112,466